BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6777838)

  • 1. New method that gives true least squares fit of one and two compartment open pharmacokinetic models applied to valproic acid and methadone.
    Lawyer CH; Gerber N
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):253-68. PubMed ID: 6777838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iterative least-squares fitting programs in pharmacokinetics for a programmable handheld calculator.
    Messori A; Donati-Cori G; Tendi E
    Am J Hosp Pharm; 1983 Oct; 40(10):1673-84. PubMed ID: 6688925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the two-compartment open model with Michaelis-Menten elimination kinetics to valproic acid in the bile-exteriorized rat.
    Lawyer CH; Gerber N; Lynn RK; Dickinson RG
    Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):469-84. PubMed ID: 6770426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of population pharmacokinetic parameters using destructively obtained experimental data: a simulation study of the one-compartment open model.
    Lindstrom FT; Birkes DS
    Drug Metab Rev; 1984; 15(1-2):195-264. PubMed ID: 6745082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis program MULTI(ELS) based on extended nonlinear least squares method for microcomputers.
    Yamaoka K; Tanaka H; Okumura K; Yasuhara M; Hori R
    J Pharmacobiodyn; 1986 Feb; 9(2):161-73. PubMed ID: 3754893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of compartment models in the pharmacokinetics].
    Weiss M; Förster W
    Z Gesamte Inn Med; 1976 Sep; 31(17):673-9. PubMed ID: 997662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estimation of pharmacokinetic constants in irregular repeated drug administration (author's transl)].
    Ringwelski L; Krause D
    Arzneimittelforschung; 1978; 28(10):1766-70. PubMed ID: 582681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of pharmacokinetic parameters on the body weight.
    Weiss M; Sziegoleit W; Förster W
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):572-5. PubMed ID: 598952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STRIPACT, an interactive curve fit programme for pharmacokinetic analyses.
    Leferink JG; Maes RA
    Arzneimittelforschung; 1979; 29(12):1894-8. PubMed ID: 546430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic analysis of ampicillin concentration in neonates: comparison of two pharmacokinetic models and of two numerical methods.
    Hermans J; Driessen O; Sorgedrager N; Spoor M
    Arzneimittelforschung; 1975 Jun; 25(6):947-9. PubMed ID: 1174334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: A critical analysis of the "flip-flop" phenomenon in the two compartment pharmacokinetic model.
    Byron PR; Notari E
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():71P. PubMed ID: 2748
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of pharmacokinetic parameters determined by four different methods.
    Parab PV; Ritschel WA; Coyle DE; Denson DD
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):251-60. PubMed ID: 3600100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the modified one-compartment open model in pharmacokinetic investigations.
    Bialik W
    Pharmazie; 1985 Feb; 40(2):120-1. PubMed ID: 4001147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of plasmatic plasminogen activator in rabbits.
    González Rey JR; Cuevas Valdespino M; Cardona M; Díaz A; Gongora C; Pérez B; Sánchez J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):171-6. PubMed ID: 2459015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic prediction of tissue residues.
    Dittert LW
    J Toxicol Environ Health; 1977 Mar; 2(4):735-56. PubMed ID: 857040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of stable labelled drugs in clinical pharmacokinetic investigations.
    Eichelbaum M; von Unruh GE; Somogyi A
    Clin Pharmacokinet; 1982; 7(6):490-507. PubMed ID: 6819104
    [No Abstract]   [Full Text] [Related]  

  • 18. Calculator programs for weighted least-squares iterative fits in pharmacokinetics.
    Ruffo S; Messori A; Donati-Cori G; Tendi E; Rosselli P; Varini C
    Am J Hosp Pharm; 1985 Mar; 42(3):628-30. PubMed ID: 3838617
    [No Abstract]   [Full Text] [Related]  

  • 19. Critical analysis of the discrepancy between V(beta) and V(ss) for drugs exhibiting different two-compartment disposition profiles.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2005 Mar; 26(2):51-8. PubMed ID: 15614832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of PKM-MULTI program for fitting discontinuous absorption profiles using a microcomputer.
    Kaniwa N; Aoyagi N; Ogata H
    J Pharmacobiodyn; 1984 Dec; 7(12):900-9. PubMed ID: 6549471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.